Facebook
X
LinkedIn
ForwardA Beautiful Nightmare
This activity will review facial aesthetics, anatomy, and safety, including vascular risk zones, adverse event recognition, and prevention strategies. Participants will also review treatment protocols, emergency preparedness, and legal precautions to ensure safe and effective patient care.
Target Audience
This activity is designed for an audience of physicians, physician assistants, nurse practitioners, nurses, dentists and other healthcare professionals.
Learning Objectives
Upon completion of the educational activity, participants should be able to:
• Define the concept of beauty in humans.
• Identify the facial structures that influence facial beauty.
• List the factors that can increase or decrease patient safety.
• Describe safety mechanisms that can be implemented in daily clinical practice.
• Summarize the latest updates regarding the facial vascular system.
• Identify which arteries pose high versus low risk for causing adverse events.
• Summarize the latest updates regarding the facial vascular system.
• Identify which arteries pose high versus low risk for causing adverse events.
• List the factors that contribute to adverse events.
• Explain mechanisms that can be implemented to prevent adverse events.
• List the factors that contribute to adverse events.
• Explain mechanisms that can be implemented to prevent adverse events.
• Describe the complexities of labial anatomy.
• Identify vascular danger zones of the lips and demonstrate how to avoid them.
• Recognize the clinical presentation of vascular adverse events.
• Differentiate the skin changes associated with different types of adverse events.
• Describe the complexities of midfacial anatomy.
• Identify vascular danger zones of the midface and demonstrate how to avoid them.
• Describe the relevant anatomy for biostimulator treatments.
• List the drugs required for treating adverse vascular events.
• List the drugs and materials needed in an emergency toolbox.
• Describe the complexities of nasolabial anatomy.
• Identify vascular danger zones of the nasolabial fold and demonstrate how to avoid them.
• Describe the complexities of nose, glabella, and forehead anatomy.
• Identify vascular danger zones of the nose, glabella, and forehead and demonstrate how to avoid them.
• Summarize the latest updates on facial ultrasound.
• Identify how adverse events present during ultrasound imaging.
• Review the current treatment options for adverse events.
• Discuss the flooding protocol and explain how it can be used for adverse event treatment.
• Outline the proper steps and measures to take after the initial treatment of vascular adverse events.
• Describe the correct treatment timeline and select appropriate drugs to use at each stage.
• Explain the legal aspects following adverse events.
• Describe precautionary measures that can be implemented to protect from legal issues.
• Review precautionary measures to protect from legal trouble.
Commercial Support
There is no commercial support for this activity.
Sebastian Cotofana, MD, PhD, has disclosed no financial relationships.
Mariana Calomeni, MD, discloses the following financial relationship: Allergan Aesthetic - Speaker, Evolus - Speaker, L’Oréal Group - Research collaboration
Christian Subbio, MD, discloses the following financial relationship: Speaker - Sciton, Prollenium
Dorothy Caputo, MA, BSN, RN, AKH Lead Nurse Planner/Reviewer: has disclosed no financial relationships.
Rebecca Lakofsky, BSN, RN, Nurse Reviewer: has disclosed no financial relationships.
Patricia Brignoni, AKH Director of Operations/Reviewer: has disclosed no financial relationships.
All of the relevant financial relationships listed for these individuals have been mitigated.
Disclosures
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Cotofana Anatomy. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 13.5 Interprofessional Continuing Education (IPCE) credit for learning and change.
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 13.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing
Credit being awarded: 13.5 ANCC contact hours
Physician Associates
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 13.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Dentists
AKH Inc., Advancing Knowledge in Healthcare is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.
AKH Inc., Advancing Knowledge in Healthcare designates this activity for 13.5 continuing education credits.
Concerns or complaints about a CE provider may be directed to the provider, or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.
Available Credit
- 13.50 AAPA Category 1 CME
- 13.50 ADA CERP
- 13.50 AMA PRA Category 1 Credit™
- 13.50 ANCC
- 13.50 Attendance